Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects
Advanced Science · 2026-05 · 13 (29)
DOI: 10.1002/advs.202521684 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 19.02.2026. Verfasst von Jiabeini Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Bacterial Outer Membrane, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Beijing Municipal Science & Technology Commission.
Abstract (Originalsprache)
Cancer immunotherapy is increasingly moving toward personalized, precision‐based strategies, with cancer vaccines emerging as a promising approach to reshape treatment. However, despite their potential, current tumor vaccines often yield limited clinical responses and subpar immunogenicity, underscoring the urgent need for innovative delivery systems to enhance immune activation. Bacterial outer membrane vesicles (OMVs), which possess natural immunomodulatory properties and impressive engineering flexibility, have attracted attention as versatile platforms for vaccine development and bioengineering applications. This review thoroughly summarizes recent advances in using OMVs to enhance the effectiveness of cancer vaccines. First, we explain the key biological features of OMVs that support their immunotherapeutic potential. Next, we carefully analyze the primary mechanisms by which OMVs enhance immune responses, as well as cutting‐edge engineering strategies to improve their safety, immunogenicity, and specificity. Additionally, we discuss the significant challenges that hinder the clinical use of OMV‐based cancer vaccines and provide a comprehensive review of current progress and future outlooks. Looking forward, combining artificial intelligence, tumor microenvironment profiling, and neoantigen discovery is expected to drive the development of next‐generation, personalized OMV‐based immunotherapies. Overall, OMVs stand out as a transformative platform capable of overcoming major obstacles in cancer vaccine development and pushing forward future cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
- Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Emergency Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.
ORCID-Profile: Jiabeini Zhang, Xiao Zhao
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Beijing Municipal Science & Technology Commission
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhang, J., Shao, T., Qu, F., Bai, C., Li, S., Gao, P., Li, W., Cheng, K., Zhao, X., & Fan, Z. (2026). Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects. Advanced Science, 13(29). https://doi.org/10.1002/advs.202521684
Vancouver
Zhang J, Shao T, Qu F, Bai C, Li S, Gao P, et al. Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects. Advanced Science. 2026;13(29). doi:10.1002/advs.202521684
BibTeX
@article{Zhang2026,
author = {Zhang, Jiabeini and Shao, Tianyu and Qu, Fengjiang and Bai, Caiyun and Li, Sijie and Gao, Pin and Li, Wenna and Cheng, Keman and Zhao, Xiao and Fan, Zhimin},
title = {Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {29},
doi = {10.1002/advs.202521684}
}
EUVIMED